XM does not provide services to residents of the United States of America.
P
P

Paypal

News

PayPal - Enabling Its U.S. Merchants To Buy, Hold And Sell Cryptocurrency Directly From Their PayPal Business Account

BRIEF-PayPal - Enabling Its U.S. Merchants To Buy, Hold And Sell Cryptocurrency Directly From Their PayPal Business Account Sept 25 (Reuters) - PayPal Holdings Inc PYPL.O : PAYPAL - ENABLING ITS U.S. MERCHANTS TO BUY, HOLD AND SELL CRYPTOCURRENCY DIRECTLY FROM THEIR PAYPAL BUSINESS ACCOUNT PAYPAL - AT LAUNCH, THIS FUNCTIONALITY FOR BUSINESS ACCOUNT
P

PayPal to allow cryptocurrency buying, holding and selling for US merchants

UPDATE 2-PayPal to allow cryptocurrency buying, holding and selling for US merchants Adds background in paragraphs 3,5,6, details from release in paragraphs 4,7 Sept 25 (Reuters) - PayPal Holdings PYPL.O announced on Wednesday it is enabling U.S. merchants to buy, hold and sell cryptocurrency from their business accounts. Cryptocurrency has moved from being a nascent asset class towards greater market acceptance after bitcoin exchange traded funds were approved for listing by the U.S.
P

US accuses Visa of monopolizing debit card swipes

UPDATE 4-US accuses Visa of monopolizing debit card swipes Prosecutors say Visa used threats, incentives to thwart competition in debit processing Visa says it will fight the claims, which it calls meritless Justice Department officials said Visa's conduct imposed hidden costs on consumers Updates with closing share price, adds comment from Visa in paragraphs 4-5, adds attempts to seek fintech companies' comments in paragraph 10, adds bullets By Jody Godoy Sept 24 (Reuters) - Visa V.N shares too
A
P
V

U.S. Cardinal Health, Factset, Paylocity

U.S. RESEARCH ROUNDUP-Cardinal Health, Factset, Paylocity Sept 23 (Reuters) - .Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cardinal Health, Factset and Paylocity Holding on Monday. HIGHLIGHTS * Cardinal Health Inc CAH.N : Baird raises target price to $140 from $137 * Factset FDS.N : Jefferies raises target price to $486 from $435 * Marinus Pharmaceuticals Inc MRNS.O : Oppenheimer raises to outperform from perform * Paylocity
B
P
V
A
P
C
D
L
L
U

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Tesla Inc TSLA.OQ +6.7% KLA Corp KLAC.OQ +6.2% Advanced Micro Devices Inc AMD.OQ +6.0% PayPal Holdings Inc PYPL.OQ +6.0% Applied Materials Inc AMAT.OQ +6.0% Bottom Performers Percent Change Moderna Inc MRNA.OQ -2.6% Dollar Tree Inc DLTR.OQ -2.5% Charter Communications Inc CHTR.OQ -2.1% American Electric Power Company Inc AEP.OQ -1.4% Warner Bros Discovery Inc WBD.OQ -1.2% The Nasd
C
P
T
A
D
K
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.